TNF and COVID-19: The UC-MSC treatment group is characterized by a reduction in the levels of inflammatory molecules, including IFN-γ, IL-6, and TNF-α cytokines, and regulated on activation, normal T cell expressed and secreted chemokine (RANTES) in COVID-19 patients.